Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

    (Submitter supplied) The aims of this study were to assess the feasibility of prospective pharmacogenomics research in multicenter international clinical trials of bortezomib in multiple myeloma and to develop predictive classifiers of response and survival with bortezomib. Patients with relapsed myeloma enrolled in phase 2 and phase 3 clinical trials of bortezomib and consented to genomic analyses of pretreatment tumor samples. more...
    Organism:
    Homo sapiens
    Type:
    Expression profiling by array
    Platforms:
    GPL96 GPL97
    528 Samples
    Download data:
    GEO (TXT)
    Series
    Accession:
    GSE9782
    ID:
    200009782

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk